TNF and neoplasm: In RIP1‐Tag5 tumours, which were devoid of immune infiltrates, treatment with TNFα‐CSG (5 daily i.v. injections of 2 or 5 μg) caused a significant influx of CD8+ and CD4+ T cells and macrophages (Fig 3A).